DekaBank Deutsche Girozentrale - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$152
-10.1%
9,0000.0%0.00%
Q4 2022$169
-99.9%
9,0000.0%0.00%
-100.0%
Q3 2022$217,000
+32.3%
9,0000.0%0.00%
Q2 2022$164,000
-16.3%
9,0000.0%0.00%
Q1 2022$196,000
-32.9%
9,000
+9.8%
0.00%
-100.0%
Q4 2021$292,000
+15.0%
8,200
+2.5%
0.00%0.0%
Q3 2021$254,000
-2.3%
8,0000.0%0.00%0.0%
Q2 2021$260,000
+51.2%
8,0000.0%0.00%0.0%
Q1 2021$172,000
+9.6%
8,0000.0%0.00%0.0%
Q4 2020$157,0008,0000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders